The contract guarantees Eckert & Ziegler a one-time payment of EUR 10 million and additional royalties on Ac-225 sales. For Eckert & Ziegler the licence and collaboration agreement is an important ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

Looking for a long-range EV SUV? The Tesla Model Y and Hyundai Ioniq 5 are two great choices. But which is the better one?

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...

With extensive industry leadership experience, Mr. Oliverio is poised to drive Actineer’s global expansion in Actinium-225 (Ac-225) production. Mr. Oliverio joins Actineer with over three ...

Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation follows ...

Shares of Ashok Leyland surged by up to 2.6% after the company posted a 36% YoY increase in consolidated net profit for ...

PennDOT announced on Jan. 31 that a small bridge on Tourist Park Road in Halifax Township will be closed due to deterioration ...

225 Ac-SSO110 (satoreotide) is a first in class Actinium-labelled SSTR2 receptor antagonist Phase I/II SANTANA-225 study on track to enrol patients in Q1 2025 BERLIN, Jan. 14, 2025 /PRNewswire ...

The CSIR NET December 2024 exam will be conducted from February 28 to March 2, 2025. The city intimation slip will inform ...

It took awhile, but all the angst over building a health clinic inside the new Grand Junction High School has cleared up like a runny nose on antihistamines.